ZYNERBA PHARMACEUTICALS, INC. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/2461d815-97dc-4077-9938-a8a526998791/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-35.3M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-004765 |
| FY 2021 | $-36.8M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-002451 |
| FY 2020 | $-52.1M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-002669 |
| FY 2019 | $-34.3M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002280 |
| FY 2018 | $-40.4M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001742 |
| FY 2017 | $-32.8M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001906 |
| FY 2016 | $-23.2M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-002155 |
| FY 2015 | $-12.5M | 2015-01-01 – 2015-12-31 | evidence 0001558370-16-004082 |
| FY 2014 | $-5.7M | 2014-01-01 – 2014-12-31 | evidence 0001558370-16-004082 |
| FY 2013 | $-634.4k | 2013-01-01 – 2013-12-31 | evidence 0001558370-16-004082 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ZYNERBA PHARMACEUTICALS, INC. — all facts · Revenue · Net Income